Mike Pellini

Mike Pellini

Director/Board Member en Personalized Medicine Coalition .

Consumer Services
Health Services
Commercial Services

Perfil

Mike Pellini is currently a Director at Mission Hospital Foundation, Personalized Medicine Coalition, Vineti, Inc., Tango Therapeutics Sub, Inc., Thrive Earlier Detection Corp., Cradle Genomics, Inc., Octave Health Group, Inc., Go2 Foundation For Lung Cancer, Exai Bio, Inc., and a Member-Presidents Leadership Council at Thomas Jefferson University.
He was formerly the Chairman, President & Chief Executive Officer at Foundation Medicine, Inc. from 2011 to 2018.
Pellini holds an MBA from Drexel University, an undergraduate degree from Boston College, and a doctorate from Sidney Kimmel Medical College.

Cargos activos de Mike Pellini

EmpresasCargoInicio
Director/Board Member -
Mission Hospital Foundation Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Go2 Foundation For Lung Cancer Director/Board Member -
Thomas Jefferson University Corporate Officer/Principal -
░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Todos los cargos activos de Mike Pellini

Antiguos cargos conocidos de Mike Pellini.

EmpresasCargoFin
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Mike Pellini.

Formación de Mike Pellini.

Drexel University Masters Business Admin
Boston College Undergraduate Degree
Sidney Kimmel Medical College Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mike Pellini.

Relaciones

100 +

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas10
Mission Hospital Foundation

Commercial Services

Health Services

Health Services

Health Technology

Health Technology

Commercial Services

Health Services

Go2 Foundation For Lung Cancer

Technology Services

Ver las conexiones de la empresa